ABI-1968 PM

CAS No. 1274711-50-0

ABI-1968 PM( —— )

Catalog No. M35983 CAS No. 1274711-50-0

ABI-1968 PM is a derivative of ABI-1968, an apoptosis-stimulating agent and an inhibitor of viral replication.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 126 In Stock
10MG 192 In Stock
25MG 314 In Stock
50MG 421 In Stock
100MG 578 In Stock
200MG 775 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    ABI-1968 PM
  • Note
    Research use only, not for human use.
  • Brief Description
    ABI-1968 PM is a derivative of ABI-1968, an apoptosis-stimulating agent and an inhibitor of viral replication.
  • Description
    ABI-1968 PM is a derivative of ABI-1968, an apoptosis-stimulating agent and an inhibitor of viral replication.ABI-1968 can be used to study cervical intraepithelial neoplasia, papillomavirus infection, and squamous intraepithelial lesions.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    Others
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1274711-50-0
  • Formula Weight
    209.21
  • Molecular Formula
    C8H11N5O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C(COC)N1C2=C(N=C1)C(=O)N=C(N)N2
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • TCS 1105

    TCS 1105 is a GABAA benzodiazepine receptor (BZR) ligand. TCS 1105 blocks Sema3A induced axonal growth cones collapse. TCS 1105 reduces anxiety-like behavior and enhances offensive behavior and social dominance in mice.

  • 1-IODOADAMANTANE

    1-Iodoadamantane is employed in the free-radical carbonylation reactions with alkenes.

  • R121919

    R121919 (NBI30775) is a potent small molecule antagonist of the adrenocorticotropic hormone-releasing factor receptor 1 (CRF1), demonstrating antidepressant and anxiolytic activity, and inhibiting the CRF1 receptor, CRF2 receptor, and CRF-binding proteins.